Parkman Healthcare Partners’s Zimmer Biomet ZBH Stock Holding History

Parkman Healthcare Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.4M	Buy	269,557 +118,508	+78%	+$10.9M	2.51%	12
2025 Q4	$13.6M	Sell	151,049 -100,371	-40%	-$9.52M	1.29%	26
2025 Q3	$24.8M	Buy	251,420 +11,025	+5%	+$1.09M	2.58%	8
2025 Q2	$21.9M	Buy	240,395 +39,895	+20%	+$3.86M	2.52%	9
2025 Q1	$22.7M	Buy	+200,500	New	+$21.4M	2.69%	11
2023 Q4	–	Sell	-71,000	Closed	-$7.97M	–	106
2023 Q3	$7.97M	Buy	+71,000	New	+$9.02M	1.46%	21
2023 Q2	–	Sell	-65,000	Closed	-$8.4M	–	104
2023 Q1	$8.4M	Buy	+65,000	New	+$8.16M	1.83%	22
2020 Q1	–	Sell	-97,850	Closed	-$14.2M	–	78
2019 Q4	$14.2M	Buy	+97,850	New	+$13.5M	4.11%	3

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's ZBH Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Zimmer Biomet (ZBH) stake by 78% in Q1 2026, buying an estimated $10.9M and bringing the position to 269,557 shares worth $24.4M. The position accounts for 2.51% of the portfolio, ranked #12.

Parkman Healthcare Partners first reported a position in ZBH in Q4 2019 and has held it in 8 quarters since. The position peaked at $24.8M in Q3 2025. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Parkman Healthcare Partners held 269,557 shares of Zimmer Biomet worth $24.4M as of Q1 2026.
Parkman Healthcare Partners bought 118,508 Zimmer Biomet shares in Q1 2026, an estimated $10.9M.
Zimmer Biomet made up 2.51% of Parkman Healthcare Partners's portfolio in Q1 2026, its #12 holding.
Parkman Healthcare Partners first reported a position in Zimmer Biomet in Q4 2019 and has held it in 8 quarters since.
Parkman Healthcare Partners's Zimmer Biomet position peaked at $24.8M in Q3 2025.
914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.